Lukas Bollenbach

Mr. Lukas Bollenbach

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2022 in Nanoscale
Verified
Journal Article
Closed access
PDF file
PLPhilipp Lapuhs
Philipp Lapuhs
EHEilien Heinrich
Eilien Heinrich
RGRonald Garcia
Ronald Garcia
Adriely GoesAdriely Goes
Adriely Goes
NFNicolas Frank
Nicolas Frank
GFGregor Fuhrmann
Gregor Fuhrmann
Outer membrane vesicles are small, lipid-based vesicles shed from the outer membrane of Gram-negative bacteria.

2 March 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JWJohanna Weber
Johanna Weber
TDTim Diederichs
Tim Diederichs
LBLukas Bollenbach
Lukas Bollenbach
PGPatrick Garidel
Patrick Garidel
Karsten MäderKarsten Mäder
Karsten Mäder
Background/Objectives: Surfactants are commonly used to protect proteins from denaturation and particle formation, thereby ensuring the long-term stability of biopharmaceuticals. Polysorbates (PS) 20 and 80 are the most widely used surfactants in the pharmaceutical industry. However, alternative excipients such as poloxamers are currently under investigation. In this study, mixed micelles (MMs) composed of phospholipids (PL) and polysorbate 20 (PS20) were explored as a novel stabilisation strategy, aiming to reduce the PS content in protein formulations by partial substitution with PL. Despite their favourable properties, including thermodynamic stability and small particle size, MMs have seen limited application, and no reports exist on their use for stabilising antibody solutions. Results: In a first step, PS20/PL ratios were identified, which are advantageous to form stable MM solutions, followed by an optimization of the formulation process by introducing a second heating step using the direct dispersion method. Successful MM formation was confirmed via transmission and dynamic light scattering analyses at total surfactant concentrations of up to 20 mg·mL−1 and 50 mg·mL−1, with PL contents of 50% and up to 40%, respectively. These surfactant concentrations of up to 20 mg·mL−1 and 50 mg·mL−1 are substantially higher than the surfactant concentrations that are typically used in final biopharmaceutical formulations (0.01–2 mg·mL−1). Consequently, the mixed micellar system enables operation even at concentrations substantially above practical formulation limits. In the ensuing study, the stabilizing potential of the PL/PS20 micellar system was appraised through agitation studies. Methods: In these studies, bovine serum albumin was employed as a model protein, while a monoclonal antibody was used as a candidate therapeutic molecule. Stability was assessed through visual inspection, turbidity measurements, particle analysis, and size-exclusion chromatography. Conclusions: A protective effect comparable to that of PS20 alone was observed for both model proteins, demonstrating for the first time that MMs can effectively stabilise biologics.

24 September 2025 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Open access
LBLukas Bollenbach
Lukas Bollenbach
TSTorsten Schultz-Fademrecht
Torsten Schultz-Fademrecht
Karsten MäderKarsten Mäder
Karsten Mäder
PGPatrick Garidel
Patrick Garidel

11 November 2026 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
JWJohanna Weber
Johanna Weber
LBLukas Bollenbach
Lukas Bollenbach
TDTim Diederichs
Tim Diederichs
PGPatrick Garidel
Patrick Garidel
Karsten MäderKarsten Mäder
Karsten Mäder

7 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
LBLukas Bollenbach
Lukas Bollenbach
JWJohanna Weber
Johanna Weber
TSTorsten Schultz-Fademrecht
Torsten Schultz-Fademrecht
Karsten MäderKarsten Mäder
Karsten Mäder
PGPatrick Garidel
Patrick Garidel
The importance of biologics has increased over the last few decades. Since proteins in liquid formulations tend to form protein particles in response to external stress factors, surfactants are added to prevent this. Currently, polysorbates (PSs) 20 and 80 are mainly used for this purpose. However, alternatives are being investigated, as PSs have stability issues, primarily due to oxidative or enzymatic degradation. The alternative that is discussed most frequently and already used in commercial biologics is poloxamer 188 (P188). However, this triblock copolymer, which consists of a polyoxypropylene block flanked by polyoxyethylene units, may also degrade through oxidative processes. Surprisingly, there are no direct comparative stability studies for PSs and P188. Therefore, the present study compared the oxidative degradation profiles of PS20 and PS80 with those of P188 in various relevant buffer systems. To this end, the formulations were subjected to stress in the form of 50 ppb (approximately 0.9 µM) of Fe²⁺ and light in the visible range, in line with their exposure during pharmaceutical production. Samples that received neither an iron spike nor light served as controls. The solutions contained 0.4 mg∙mL−1 PS20, PS80, or P188, respectively. The surfactants were formulated in either a 25 mM acetate, citrate, or histidine buffer solution (all pH 5.5) or in pure water. Significant differences were observed between these buffers, with greater effects at higher temperatures. The stability of the surfactant depended greatly on the buffer and the applied stress. All surfactants exhibited high rates of oxidative degradation when formulated in acetate buffer or pure water. PSs demonstrated the highest overall stability in citrate buffer, while P188 remained most stable in histidine, as well as in citrate buffer. However, both PSs exhibited instability in the presence of iron and light in histidine buffer, a phenomenon not observed in P188.

3 August 2026 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
LBLukas Bollenbach
Lukas Bollenbach
JWJohanna Weber
Johanna Weber
TSTorsten Schultz-Fademrecht
Torsten Schultz-Fademrecht
Karsten MäderKarsten Mäder
Karsten Mäder
PGPatrick Garidel
Patrick Garidel